Abad-Santos F, Carcas AJ, Ibanez C, Frias J. Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin toxicity. Ther Drug Monit 2000;22(2):163–8. https://www.ncbi.nlm.nih.gov/pubmed/10774627
Australian and New Zealand Committee on Resuscitation. Cardiorespiratory arrest flowcharts. East Melbourne: Australian Resuscitation Council; 2016. https://resus.org.au/guidelines/flowcharts-3/
Chan BS, Buckley NA. Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clin Toxicol (Phila) 2014;52(8):824–36. https://www.ncbi.nlm.nih.gov/pubmed/25089630
Chan BS, Isbister GK, O’Leary M, Chiew A, Buckley NA. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). Clin Toxicol (Phila) 2016;54(6):488–94. https://www.ncbi.nlm.nih.gov/pubmed/27118413
Chan BS, Isbister GK, Page CB, Isoardi KZ, Chiew AL, Kirby KA, et al. Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4). Clin Toxicol (Phila) 2019;57(7):638–43. https://www.ncbi.nlm.nih.gov/pubmed/30585517
Levine M, Nikkanen H, Pallin DJ. The effects of intravenous calcium in patients with digoxin toxicity. J Emerg Med 2011;40(1):41–6. https://www.ncbi.nlm.nih.gov/pubmed/19201134
